The characteristics of premature infants with transient corneal haze
- PMID: 29596534
- PMCID: PMC5875869
- DOI: 10.1371/journal.pone.0195300
The characteristics of premature infants with transient corneal haze
Abstract
Background: The etiology of transient corneal haze in premature infants is not known and how it relates to clinical outcomes in premature infants is not clear.
Objectives: To study associated factors of transient corneal haze in premature infants.
Methods: We performed a retrospective study of 261 premature infants from retinopathy of prematurity (ROP) screening in the neonatal intensive care unit at a tertiary referral hospital. Characteristics of premature infants with and without corneal haze were analyzed by correlation tests, Chi-square tests, and logistic regressions were used for statistical analyses. Associations between corneal haze and birth weight (BW), gestational age at birth (GA), central corneal thickness, intraocular pressure, and other systemic and ophthalmic data were evaluated.
Results: The incidence of corneal haze was 13.4%. Lower BW, lower GA, packed red blood cells (RBC) transfusion, more days on oxygen, older maternal age, bronchopulmonary disease, and stage 3 ROP are associated with corneal haze. The severity of corneal haze decreased with infants' postmenstrual age. Multivariate logistic regression analyses revealed that BW and maternal age are the most important predictors of corneal haze.
Conclusion: Low BW and older maternal age are the most important predictors of corneal haze in premature infants. Premature infants with corneal haze could carry more systemic and ocular morbidities. Hence they may require more clinical attention. Corneal haze is unlikely to hinder the treatment of ROP. However, it is possible that corneal haze could hinder the examination of ROP in some infants. If corneal haze does interfere with ROP screening, a closer, more conservative follow-up schedule with a senior ophthalmologist experienced in managing ROP is recommended.
Conflict of interest statement
Figures



Similar articles
-
Retinopathy of prematurity in Korean infants with birthweight greater than 1500 g.Br J Ophthalmol. 2016 Jun;100(6):834-8. doi: 10.1136/bjophthalmol-2015-306960. Epub 2015 Oct 19. Br J Ophthalmol. 2016. PMID: 26483442
-
Intraocular Hemorrhages and Retinopathy of Prematurity in the Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study.Ophthalmology. 2017 Mar;124(3):374-381. doi: 10.1016/j.ophtha.2016.10.040. Epub 2016 Dec 13. Ophthalmology. 2017. PMID: 27986386 Free PMC article.
-
[Screening analysis of retinopathy of prematurity and treatment of threshold retinopathy of prematurity].Zhonghua Yan Ke Za Zhi. 2006 Jun;42(6):496-500. Zhonghua Yan Ke Za Zhi. 2006. PMID: 16857127 Chinese.
-
Retinopathy of Prematurity among Very-Low-Birth-Weight Infants in Korea: Incidence, Treatment, and Risk Factors.J Korean Med Sci. 2015 Oct;30 Suppl 1(Suppl 1):S88-94. doi: 10.3346/jkms.2015.30.S1.S88. Epub 2015 Oct 27. J Korean Med Sci. 2015. PMID: 26566363 Free PMC article.
-
Retinopathy of prematurity in Indonesia: Incidence and risk factors.J Neonatal Perinatal Med. 2017;10(1):85-90. doi: 10.3233/NPM-915142. J Neonatal Perinatal Med. 2017. PMID: 28304327 Review.
Cited by
-
Staged lensectomy and vitrectomy in the management of stage 5C retinopathy of prematurity with corneal opacification: long-term follow up.Int J Ophthalmol. 2022 Sep 18;15(9):1437-1443. doi: 10.18240/ijo.2022.09.05. eCollection 2022. Int J Ophthalmol. 2022. PMID: 36124179 Free PMC article.
References
-
- Edelhauser HF. The balance between corneal transparency and edema: the Proctor Lecture. Invest Ophthalmol Vis Sci. 2006;47(5):1754–67. doi: 10.1167/iovs.05-1139 - DOI - PubMed
-
- Qazi Y, Wong G, Monson B, Stringham J, Ambati BK. Corneal transparency: genesis, maintenance and dysfunction. Brain Res Bull. 2010;81(2–3):198–210. doi: 10.1016/j.brainresbull.2009.05.019 - DOI - PMC - PubMed
-
- Chiambaretta F, De Graeve F, Turet G, Marceau G, Gain P, Dastugue B, et al. Cell and tissue specific expression of human Kruppel-like transcription factors in human ocular surface. Mol Vis. 2004;10:901–9. - PubMed
-
- Hassell JR, Birk DE. The molecular basis of corneal transparency. Exp Eye Res. 2010;91(3):326–35. doi: 10.1016/j.exer.2010.06.021 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical